---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-018048"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2025-02-11T23:59:59+00:00"
generated_at: "2026-05-26T23:20:08.739993+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CV Sciences disputes Extract Labs acquisition termination by Sellers; evaluating options

## Summary
- On Feb 5, 2025, Extract Labs owners informed CV Sciences they cannot close due to alleged failure to obtain bank consent, purportedly terminating the Stock Purchase Agreement.
- CV Sciences disputes the Sellers' right to terminate and reserves all rights; evaluating legal options.
- The Purchase Agreement was entered on Nov 21, 2024, for CV Sciences to acquire all outstanding shares of Extract Labs.

## SEC filing metadata
- accession: 0000950170-25-018048
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2025-02-11T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.02, 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000095017025018048/0000950170-25-018048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000095017025018048/cvsi-20250205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-018048
- JSON: https://secwatch.observer/filing/0000950170-25-018048.json
- Plain text: https://secwatch.observer/filing/0000950170-25-018048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.